Singapore markets closed

Eupraxia Pharmaceuticals Inc. (EPRX.TO)

Toronto - Toronto Real-time price. Currency in CAD
Add to watchlist
1.0800+0.0800 (+8.00%)
At close: 02:44PM EDT
Full screen
Previous close1.0000
Open1.0700
Bid1.0000 x N/A
Ask1.1800 x N/A
Day's range1.0500 - 1.0800
52-week range0.8000 - 3.5000
Volume4,111
Avg. volume22,450
Market cap23.105M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-1.2720
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est6.75
  • CNW Group

    Eupraxia Pharmaceuticals Recognized as Emerging Life Sciences Company of the Year by Life Sciences British Columbia

    Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a clinical-stage biotechnology company with an innovative drug delivery platform technology, announced today that it has been awarded The Emerging Life Sciences Company of the Year Award by Life Sciences British Columbia ("LSBC").

  • CNW Group

    Eupraxia Pharmaceuticals to Present at BIO International Convention

    Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX) a clinical-stage biotechnology company with an innovative drug delivery platform technology, announced today that its CEO, Dr. James Helliwell, will present at the 2022 Bio International Convention being held at the San Diego Convention Center from June 13-16, 2022, in San Diego, CA.

  • CNW Group

    Eupraxia Pharmaceuticals Reports First Quarter 2022 Financial Results

    Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a Phase 2 clinical-stage biotechnology company with an innovative drug delivery technology platform, today announced its unaudited financial results (prepared in accordance with International Financial Reporting Standards or "IFRS") and operational highlights for the first quarter ended March 31, 2022. All amounts are expressed in Canadian dollars unless otherwise indicated.